Literature DB >> 33406594

The Related Risk Factors of Diabetic Retinopathy in Elderly Patients with Type 2 Diabetes Mellitus: A Hospital-Based Cohort Study in Taiwan.

Tsai-Tung Chiu1,2, Tien-Lung Tsai3, Mei-Yin Su4, Tsan Yang1, Peng-Lin Tseng5,6, Yau-Jiunn Lee2, Chao-Hsien Lee1.   

Abstract

Diabetic retinopathy (DR), caused by small vessel disease, is the main cause of blindness in persons with diabetes. Taiwan is one of the Asian countries with the highest prevalence rate of DR. The purpose was to investigate the related risk factors of DR in elderly patients with type 2 diabetes mellitus (T2DM), in Lee's Endocrinology Clinic. 792 T2DM patients over 60 years old were invited to have an outpatient visit at least every three months, and all of them were asked to undergo a standardized interview and collect their blood samples. Significant factors were being female (adjusted hazard ratio (HR): 1.287; 95% CI, 1.082-1.531), higher glycated hemoglobin (HbA1c) (HR: 1.067; 95% CI: 1.016-1.119), higher mean low density of lipoprotein cholesterol (LDL-c) (HR: 1.004; 95% CI: 1.001-1.006), and chewing betel nut (HR: 1.788; 95% CI: 1.362-2.347). This study showed that gender, the behavior of chewing betel nut, HbA1c, and LDL-c are important factors for the development of DR in elderly patients with T2DM. It is suggested that patients should control their HbA1c and LDL-c and quit chewing betel nut to prevent DR. This suggestion applies especially to female patients.

Entities:  

Keywords:  chewing betel nut; dilated fundus examination; health behavior

Mesh:

Year:  2021        PMID: 33406594      PMCID: PMC7795133          DOI: 10.3390/ijerph18010307

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


  36 in total

1.  Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.

Authors:  I M Stratton; A I Adler; H A Neil; D R Matthews; S E Manley; C A Cull; D Hadden; R C Turner; R R Holman
Journal:  BMJ       Date:  2000-08-12

2.  Effects of medical therapies on retinopathy progression in type 2 diabetes.

Authors:  Emily Y Chew; Walter T Ambrosius; Matthew D Davis; Ronald P Danis; Sapna Gangaputra; Craig M Greven; Larry Hubbard; Barbara A Esser; James F Lovato; Letitia H Perdue; David C Goff; William C Cushman; Henry N Ginsberg; Marshall B Elam; Saul Genuth; Hertzel C Gerstein; Ulrich Schubart; Lawrence J Fine
Journal:  N Engl J Med       Date:  2010-06-29       Impact factor: 91.245

Review 3.  Associations between diabetic retinopathy and systemic risk factors.

Authors:  N Wat; R Lm Wong; I Yh Wong
Journal:  Hong Kong Med J       Date:  2016-10-24       Impact factor: 2.227

Review 4.  Oxidative damage and the prevention of age-related cataracts.

Authors:  David C Beebe; Nancy M Holekamp; Ying-Bo Shui
Journal:  Ophthalmic Res       Date:  2010-09-09       Impact factor: 2.892

5.  Incidence and prevalence rates of diabetes mellitus in Taiwan: analysis of the 2000-2009 Nationwide Health Insurance database.

Authors:  Yi-Der Jiang; Chia-Hsuin Chang; Tong-Yuan Tai; Jung-Fu Chen; Lee-Ming Chuang
Journal:  J Formos Med Assoc       Date:  2012-10-23       Impact factor: 3.282

6.  The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years.

Authors:  R Klein; B E Klein; S E Moss; M D Davis; D L DeMets
Journal:  Arch Ophthalmol       Date:  1984-04

7.  High HbA1c level was the most important factor associated with prevalence of diabetic retinopathy in Taiwanese type II diabetic patients with a fixed duration.

Authors:  Shwu-Jiuan Sheu; Ni-Chun Liu; Lu-Ping Ger; Wan-Ling Ho; Jiun-Yo Lin; Shih-Chou Chen; Yu-Harn Horng; Hing-Chung Lam
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-03-17       Impact factor: 3.117

Review 8.  Global prevalence and major risk factors of diabetic retinopathy.

Authors:  Joanne W Y Yau; Sophie L Rogers; Ryo Kawasaki; Ecosse L Lamoureux; Jonathan W Kowalski; Toke Bek; Shih-Jen Chen; Jacqueline M Dekker; Astrid Fletcher; Jakob Grauslund; Steven Haffner; Richard F Hamman; M Kamran Ikram; Takamasa Kayama; Barbara E K Klein; Ronald Klein; Sannapaneni Krishnaiah; Korapat Mayurasakorn; Joseph P O'Hare; Trevor J Orchard; Massimo Porta; Mohan Rema; Monique S Roy; Tarun Sharma; Jonathan Shaw; Hugh Taylor; James M Tielsch; Rohit Varma; Jie Jin Wang; Ningli Wang; Sheila West; Liang Xu; Miho Yasuda; Xinzhi Zhang; Paul Mitchell; Tien Y Wong
Journal:  Diabetes Care       Date:  2012-02-01       Impact factor: 19.112

9.  Standards of medical care in diabetes-2015 abridged for primary care providers.

Authors: 
Journal:  Clin Diabetes       Date:  2015-04

10.  Association of statin use and hypertriglyceridemia with diabetic macular edema in patients with type 2 diabetes and diabetic retinopathy.

Authors:  Yoo-Ri Chung; Sung Wook Park; Shin-Young Choi; Seung Woo Kim; Ka Young Moon; Jeong Hun Kim; Kihwang Lee
Journal:  Cardiovasc Diabetol       Date:  2017-01-07       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.